Detected ·
Anagram Therapeutics, Inc.
——
Blackstone Life Sciences commits $250M to Anagram Therapeutics, a clinical-stage biopharmaceutical company developing ANG003 for a $2B market. The funding will support continued development, regulatory approval, and commercial launch.
- Website
- www.anagramtx.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-07 20:07:34 UTC
- Signal ID
- 44272037-f1ac-4cfb-9290-0653b5afb912
As the API returns it
{
"id": "44272037-f1ac-4cfb-9290-0653b5afb912",
"created_at": "2026-05-07T20:07:34.558355Z",
"company_name": "Anagram Therapeutics, Inc.",
"company_website_url": "www.anagramtx.com",
"company_linkedin_url": "https://www.linkedin.com/company/anagram-therapeutics-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Blackstone Life Sciences commits $250M to Anagram Therapeutics, a clinical-stage biopharmaceutical company developing ANG003 for a $2B market. The funding will support continued development, regulatory approval, and commercial launch.*"
}